You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康基醫療(09997.HK)擬3.51億元投資杭州唯精醫療機器人
格隆匯 01-18 22:28

格隆匯1月18日丨康基醫療(09997.HK)宣佈,於2022年1月18日,公司全資附屬公司康基醫療(香港)有限公司("康基香港")與(其中包括)杭州唯精醫療機器人有限公司("目標公司")、段香麗及潘博(與段香麗,統稱"賣方"),及目標公司的其他現有股東訂立股權投資協議。

根據協議的條款及條件:(1)康基香港有條件同意以人民幣3.40億元認購目標公司的全面稀釋基礎上的32.75%股權;(2)各賣方有條件同意出售而康基香港有條件同意以人民幣1143.5萬元收購彼等於目標公司的全面稀釋基礎上的1.125%股權(共人民幣2287萬元,相當於約2803.63萬港元,收購共2.25%股權)。

公吿稱,目標公司主要在中國從事腹腔鏡手術機器人產品及器械的研發和生產,此為正在快速發展的行業。目標公司的核心管理團隊擁有多年研發經驗及開發多孔及單孔手術機器人系統的專業知識。公司的投資標誌着其致力於打造未來手術機器人產品平台的戰略步伐,與其研發、生產、學術推廣及銷售和分銷網絡具有顯著的潛在協同效應。通過利用集團的現有平台,集團堅信目標公司能夠加快其發展及商業化進程。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account